Correlation Between Aquestive Therapeutics and Nextnav Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Nextnav Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Nextnav Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Nextnav Acquisition Corp, you can compare the effects of market volatilities on Aquestive Therapeutics and Nextnav Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Nextnav Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Nextnav Acquisition.

Diversification Opportunities for Aquestive Therapeutics and Nextnav Acquisition

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Aquestive and Nextnav is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Nextnav Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextnav Acquisition Corp and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Nextnav Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextnav Acquisition Corp has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Nextnav Acquisition go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Nextnav Acquisition

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 1.64 times less return on investment than Nextnav Acquisition. In addition to that, Aquestive Therapeutics is 1.03 times more volatile than Nextnav Acquisition Corp. It trades about 0.08 of its total potential returns per unit of risk. Nextnav Acquisition Corp is currently generating about 0.13 per unit of volatility. If you would invest  396.00  in Nextnav Acquisition Corp on August 26, 2024 and sell it today you would earn a total of  1,191  from holding Nextnav Acquisition Corp or generate 300.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Nextnav Acquisition Corp

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Aquestive Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Nextnav Acquisition Corp 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nextnav Acquisition Corp are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Nextnav Acquisition displayed solid returns over the last few months and may actually be approaching a breakup point.

Aquestive Therapeutics and Nextnav Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Nextnav Acquisition

The main advantage of trading using opposite Aquestive Therapeutics and Nextnav Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Nextnav Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextnav Acquisition will offset losses from the drop in Nextnav Acquisition's long position.
The idea behind Aquestive Therapeutics and Nextnav Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk